rxo inc - RXO
RXO
Close Chg Chg %
15.85 -0.16 -1.01%
Closed Market
15.69
-0.16 (1.01%)
Volume: 1.29M
Last Updated:
Feb 19, 2026, 3:59 PM EDT
Company Overview: rxo inc - RXO
RXO Key Data
| Open $15.67 | Day Range 15.47 - 15.89 |
| 52 Week Range 10.43 - 21.70 | Market Cap $2.22B |
| Shares Outstanding 164.19M | Public Float 160.77M |
| Beta 1.61 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$0.59 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 3.07M |
RXO Performance
| 1 Week | 16.14% | ||
| 1 Month | 4.67% | ||
| 3 Months | 36.79% | ||
| 1 Year | -22.10% | ||
| 5 Years | N/A |
RXO Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
21
Full Ratings ➔
About rxo inc - RXO
RXO, Inc. engages in providing asset-light transportation solutions. It also offers managed transportation, freight forwarding, and last mile delivery. The company was founded on May 5, 2022 and is headquartered in Charlotte, NC.
RXO At a Glance
RXO, Inc.
11215 North Community House Road
Charlotte, North Carolina 28277
| Phone | 1-980-308-6058 | Revenue | 5.74B | |
| Industry | Packaged Software | Net Income | -100,000,000.00 | |
| Sector | Technology Services | 2025 Sales Growth | 26.198% | |
| Fiscal Year-end | 12 / 2026 | Employees | 9,218 | |
| View SEC Filings |
RXO Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.371 |
| Price to Book Ratio | 1.347 |
| Price to Cash Flow Ratio | 41.75 |
| Enterprise Value to EBITDA | 25.517 |
| Enterprise Value to Sales | 0.484 |
| Total Debt to Enterprise Value | 0.241 |
RXO Efficiency
| Revenue/Employee | 622,911.695 |
| Income Per Employee | -10,848.34 |
| Receivables Turnover | 4.586 |
| Total Asset Turnover | 1.716 |
RXO Liquidity
| Current Ratio | 1.269 |
| Quick Ratio | 1.269 |
| Cash Ratio | 0.017 |
RXO Profitability
| Gross Margin | 14.368 |
| Operating Margin | -0.122 |
| Pretax Margin | -2.003 |
| Net Margin | -1.742 |
| Return on Assets | -2.989 |
| Return on Equity | -6.343 |
| Return on Total Capital | -4.523 |
| Return on Invested Capital | -4.654 |
RXO Capital Structure
| Total Debt to Total Equity | 43.478 |
| Total Debt to Total Capital | 30.303 |
| Total Debt to Total Assets | 20.446 |
| Long-Term Debt to Equity | 37.508 |
| Long-Term Debt to Total Capital | 26.142 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Rxo Inc - RXO
Collapse All in section
| All values USD millions. | 2022 | 2023 | 2024 | 2025 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 4.80B | 3.93B | 4.55B | 5.74B | |
Sales Growth
| +2.28% | -18.12% | +15.86% | +26.20% | |
Cost of Goods Sold (COGS) incl D&A
| 3.71B | 3.27B | 3.85B | 4.92B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 86.00M | 67.00M | 87.00M | 116.00M | |
Depreciation
| 65.00M | 54.00M | 59.00M | 69.00M | |
Amortization of Intangibles
| 21.00M | 13.00M | 28.00M | 47.00M | |
COGS Growth
| -1.38% | -11.89% | +17.90% | +27.58% | |
Gross Income
| 1.09B | 658.00M | 696.00M | 825.00M | |
Gross Income Growth
| +17.15% | -39.41% | +5.78% | +18.53% | |
Gross Profit Margin
| +22.64% | +16.76% | +15.30% | +14.37% |
| 2022 | 2023 | 2024 | 2025 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 866.00M | 591.00M | 666.00M | 840.00M | |
Research & Development
| - | - | - | - | - |
Other SG&A
| 866.00M | 591.00M | 666.00M | 1.02B | |
SGA Growth
| +18.47% | -31.76% | +12.69% | +26.13% | |
Other Operating Expense
| - | - | - | (8.00M) | - |
Unusual Expense
| 97.00M | 28.00M | 86.00M | 72.00M | |
EBIT after Unusual Expense
| 123.00M | 39.00M | (56.00M) | (79.00M) | |
Non Operating Income/Expense
| - | (3.00M) | (218.00M) | (1.00M) | |
Non-Operating Interest Income
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 4.00M | 32.00M | 30.00M | 35.00M | |
Interest Expense Growth
| - | +700.00% | -6.25% | +16.67% | |
Gross Interest Expense
| 4.00M | 32.00M | 30.00M | 35.00M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 119.00M | 4.00M | (304.00M) | (115.00M) | |
Pretax Income Growth
| -37.70% | -96.64% | -7,700.00% | +62.17% | |
Pretax Margin
| +2.48% | +0.10% | -6.68% | -2.00% | |
Income Tax
| - | 27.00M | (14.00M) | (15.00M) | |
Income Tax - Current - Domestic
| - | 38.00M | 7.00M | 3.00M | |
Income Tax - Current - Foreign
| 9.00M | 1.00M | 5.00M | 3.00M | |
Income Tax - Deferred - Domestic
| (20.00M) | (9.00M) | (17.00M) | (20.00M) | |
Income Tax - Deferred - Foreign
| - | 1.00M | (2.00M) | (1.00M) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 92.00M | 4.00M | (290.00M) | (100.00M) | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 92.00M | 4.00M | (290.00M) | (100.00M) | |
Net Income Growth
| -38.67% | -95.65% | -7,350.00% | +65.52% | |
Net Margin Growth
| +1.92% | +0.10% | -6.37% | -1.74% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 92.00M | 4.00M | (290.00M) | (100.00M) | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 92.00M | 4.00M | (290.00M) | (100.00M) | |
EPS (Basic)
| 0.7904 | 0.0342 | -2.1737 | -0.5936 | |
EPS (Basic) Growth
| -38.67% | -95.67% | -6,455.85% | +72.69% | |
Basic Shares Outstanding
| 116.40M | 116.87M | 133.41M | 168.46M | |
EPS (Diluted)
| 0.7904 | 0.0335 | -2.1737 | -0.5936 | |
EPS (Diluted) Growth
| -38.67% | -95.76% | -6,588.66% | +72.69% | |
Diluted Shares Outstanding
| 116.40M | 119.46M | 133.41M | 168.46M | |
EBITDA
| 306.00M | 134.00M | 117.00M | 109.00M | |
EBITDA Growth
| +10.47% | -56.21% | -12.69% | -6.84% | |
EBITDA Margin
| +6.38% | +3.41% | +2.57% | +1.90% |
Snapshot
| Average Recommendation | HOLD | Average Target Price | 15.941 | |
| Number of Ratings | 21 | Current Quarters Estimate | -0.086 | |
| FY Report Date | 03 / 2026 | Current Year's Estimate | 0.001 | |
| Last Quarter’s Earnings | -0.07 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | -0.04 | Next Fiscal Year Estimate | 0.40 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 20 | 20 | 20 | 20 |
| Mean Estimate | -0.09 | -0.02 | 0.00 | 0.40 |
| High Estimates | -0.05 | 0.03 | 0.18 | 0.75 |
| Low Estimate | -0.12 | -0.09 | -0.15 | 0.17 |
| Coefficient of Variance | -22.72 | -167.99 | 5,936.81 | 34.15 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 4 | 4 | 4 |
| OVERWEIGHT | 1 | 1 | 1 |
| HOLD | 14 | 14 | 15 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 2 | 2 | 2 |
| MEAN | Hold | Hold | Hold |
SEC Filings for Rxo Inc - RXO
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Rxo Inc - RXO
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Mar 6, 2025 | Jeffrey D. Firestone Chief Legal Officer | 16,717 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 6, 2025 | Jeffrey D. Firestone Chief Legal Officer | 172,767 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 26, 2025 | James E. Harris Chief Financial Officer | 69,702 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 26, 2025 | James E. Harris Chief Financial Officer | 59,974 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $20.14 per share | 1,207,876.36 |
| Feb 26, 2025 | James E. Harris Chief Financial Officer | 253,189 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 26, 2025 | Jason S. Kerr Chief Accounting Officer | 87,848 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 26, 2025 | Jason S. Kerr Chief Accounting Officer | 85,277 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $20.14 per share | 1,717,478.78 |
| Feb 26, 2025 | Jason S. Kerr Chief Accounting Officer | 10,514 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 26, 2025 | Andrew Wilkerson Chief Executive Officer; Director | 223,813 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 26, 2025 | Andrew Wilkerson Chief Executive Officer; Director | 188,554 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $20.14 per share | 3,797,477.56 |
| Feb 26, 2025 | Andrew Wilkerson Chief Executive Officer; Director | 521,637 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 26, 2025 | Jeffrey D. Firestone Chief Legal Officer | 145,898 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |